Ani Pharmaceuticals (NASDAQ: ANIP)
Ani Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Ani Pharmaceuticals Company Info
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
News & Analysis
Here's Why Ani Pharmaceuticals Stock Is Rocketing Higher Today
The company reported positive third-quarter earnings, and the FDA granted approval for its generic version of Acthar Gel.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
How ANI Pharmaceuticals Plans to Take Down a Price-Gouging Giant
A small-cap pharmaceuticals company may hold the solution to a 100,000% drug price hike.
3 Under-the-Radar Value Stocks to Buy in 2019
These might be the cheapest stocks you've never heard about.
3 Top Small-Cap Stocks to Buy Right Now
These stocks may be small in stature, but they're big on growth potential.
3 Small, Profitable Biotechs With Fantastic Growth
If you are looking for biotechs with high potential and low risk, Corcept Therapeutics, ANI Pharmaceuticals, and Ligand Pharmaceuticals are growing like weeds ... and actually making real profits now.
3 Top Small-Cap Stocks to Buy in August
Sometimes great things come in small packages.
4 Top Small-Cap Stocks to Buy in June
Sometimes the best stocks come in small packages.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.